Semler Scientific (NASDAQ: SMLR)
Semler Scientific Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Semler Scientific Company Info
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluates its customers’ patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler, Guinasso Cindy and Shirley L. Semler on August 9, 2007 and is headquartered in Santa Clara, CA.
News & Analysis
Why Semler Scientific Plunged 37% This Morning
The medical diagnostic company plunged after it gave soft guidance for the fourth quarter.
Why Semler Scientific Stock Is Skyrocketing Today
Investors cheered Semler's Q2 update.
Why Semler Scientific Stock Is Sinking Today
The company missed analysts' estimates with its Q1 results.
Is Semler Scientific Stock Still a Buy After Its Earnings Miss?
The company reported slowing growth, but is there hope?
This Top Small-Cap Just Became a Better Buy
With Semler moving to the Nasdaq, the company's strong business model will be more visible to investors.
Why 2021 Could Be a Breakout Year for Semler Scientific
A company most investors have never heard of is beginning to make a name for itself.
5 Top Stocks for September
No matter what the month, stay the course.
3 Healthcare Stocks That Could Make You Rich
All three offer innovative technology that meets major healthcare needs.
Valuation
Podcast Episodes
Healthcare Stocks to Watch
Healthcare stocks that look like interesting buys for 2021.
3 Healthcare Stocks to Watch
Discover how these three companies could change the face of healthcare.
3 Exciting Healthcare Stocks
We take a look at three small and promising healthcare companies across diagnostics, surgical products, and genetic testing.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.